SANXING(601567)2025-04-24 12:45Financial Performance - The company's operating revenue for Q1 2025 reached ¥3,630,793,866.31, representing a year-over-year increase of 20.03% compared to ¥3,024,788,914.34 in the same period last year[3]. - Net profit attributable to shareholders was ¥489,308,019.24, a 34.33% increase from ¥364,254,826.35 in the previous year[3]. - The basic earnings per share (EPS) increased to ¥0.35, up 34.62% from ¥0.26 in the same period last year[3]. - Operating profit for Q1 2025 was ¥567,140,535.34, up 31.0% from ¥432,786,545.03 in Q1 2024[20]. - Net profit attributable to shareholders for Q1 2025 was ¥489,308,019.24, representing a 34.4% increase compared to ¥364,254,826.35 in Q1 2024[20]. - The company reported a total comprehensive income of ¥494,688,231.23 for Q1 2025, an increase from ¥364,574,945.30 in Q1 2024[20]. - The company's revenue for Q1 2025 reached ¥543.27 million, a 22.5% increase compared to ¥443.46 million in Q1 2024[29]. - Operating profit for Q1 2025 was ¥131.69 million, up 46.6% from ¥89.78 million in Q1 2024[29]. - Net profit for Q1 2025 was ¥121.29 million, representing a 38.8% increase from ¥87.39 million in Q1 2024[30]. - The total comprehensive income for Q1 2025 was ¥79.54 million, compared to ¥72.07 million in Q1 2024[30]. - Basic and diluted earnings per share for Q1 2025 were both ¥0.09, up from ¥0.06 in Q1 2024[30]. Cash Flow and Assets - The net cash flow from operating activities was negative at -¥148,434,278.48, a decline of 149.41% compared to a positive cash flow of ¥99,347,382.01 in the previous year[3]. - Cash inflow from operating activities for Q1 2025 was CNY 3,034,317,675.10, an increase of 5.64% compared to CNY 2,872,763,896.15 in Q1 2024[23]. - Cash flow from operating activities for Q1 2025 was ¥32.65 million, a decrease of 62% compared to ¥86.08 million in Q1 2024[31]. - The company's cash and cash equivalents decreased to RMB 3.934 billion from RMB 4.539 billion[14]. - Cash and cash equivalents at the end of Q1 2025 were CNY 3,597,433,814.31, down from CNY 4,754,411,811.83 in Q1 2024[24]. - The company's cash and cash equivalents at the end of Q1 2025 were ¥633.92 million, down from ¥2.89 billion at the end of Q1 2024[32]. - The total non-current assets increased to RMB 10.877 billion from RMB 10.677 billion[15]. - The total assets of the company stood at RMB 24.530 billion, a slight increase from RMB 24.476 billion[15]. - Total assets increased to CNY 14,462,952,415.77 as of March 31, 2025, from CNY 12,932,806,743.68 a year earlier[27]. Liabilities and Equity - Total liabilities decreased to ¥11,721,971,014.71 in Q1 2025 from ¥12,202,548,432.10 in Q1 2024, a reduction of 3.9%[19]. - Total equity increased to ¥12,808,249,649.14 in Q1 2025 from ¥12,273,938,154.83 in Q1 2024, reflecting a growth of 4.4%[19]. - Total liabilities rose to CNY 5,838,070,368.35 in Q1 2025, compared to CNY 4,390,923,329.33 in Q1 2024[28]. - Shareholders' equity increased to CNY 8,624,882,047.42 in Q1 2025, up from CNY 8,541,883,414.35 in Q1 2024[28]. - The equity attributable to shareholders increased to ¥12,590,896,965.13, reflecting a growth of 4.21% from ¥12,081,698,336.27 at the end of the previous year[4]. Operational Highlights - The company reported a significant increase in net profit primarily due to growth in operating revenue and increased foreign exchange gains[7]. - The company experienced a substantial increase in material payment costs, impacting the net cash flow from operating activities negatively[7]. - The company reported a total order backlog of RMB 15.717 billion, representing a year-over-year increase of 26.12%[11]. - The overseas distribution order backlog reached RMB 1.667 billion, showing a significant year-over-year growth of 134.05%[11]. - The company continues to focus on expanding its market presence and enhancing its product offerings[11]. - Research and development expenses for Q1 2025 were ¥117,042,069.26, up 8.5% from ¥107,606,619.48 in Q1 2024[19]. - Research and development expenses increased to ¥24.18 million in Q1 2025, up 19.7% from ¥20.21 million in Q1 2024[29]. Non-Recurring Items - Non-recurring gains and losses totaled ¥29,169,695.13, with government subsidies contributing ¥16,438,417.99 to this figure[5]. - The financial expenses for Q1 2025 showed a significant improvement, with a net income of -¥46,317,353.47 compared to a cost of ¥18,471,113.41 in Q1 2024[19].